Galiya Tussupbekova, chief allergist-immunologist and head of the Allergology Center of Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, took part in the annual International Congress of the European Academy of Allergologists and Clinical Immunologists. This year the Congress was held in Hamburg from June 9 to 11. There were more than 7400 participants from all over the world.
Galiya Tussupbekova made a poster presentation on “Experience of Omalizumab treatment of severe bronchial asthma in combination with severe spring keratoconjunctivitis”.
- This Congress presented innovative methods of diagnosis and treatment of severe forms of allergic and immune-dependent diseases with a personalized and multidisciplinary approach. There was a great deal of new information, including separate sessions on hypereosinophilic syndrome, autoimmune allergies, allergies and oncology, drug allergies, food allergies and biological allergy therapy, and new options for allergen-specific immunotherapy. Much attention was given to pediatric allergies. As medicine evolves and there are more and more severe forms of allergies, it is always important for doctors to share experience and expand their knowledge,” says Galiya Tussupbekova, chief allergologist-immunologist and head of the Allergology Center at Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan.
